- Δεν υπάρχουν δεδομένα
Ελληνικά
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Tesat Spacecom's laser communication terminal announced on October 26th that the company has passed critical ground testing deployed on NASA satellites.Tesat's SCOTT80 optical terminal was selected by Lockheed Martin, one of several manufacturers producing satellites for the Space Development Agency.SDA is an agency under the United States Space Force that plans to deploy a network of interconnect...
Figure 1. The setup of Hui Zhao and his team at the University of Kansas Ultra Fast Laser Laboratory.A team of researchers from the University of Kansas's ultrafast laser laboratory recently managed to capture real-time ballistic transmission of electrons in graphene, which could lead to faster, more powerful, and more energy-efficient electronic devices in the future.The motion of electrons is of...
TORNOS walking machine, also known as walking CNC lathe or spindle box mobile CNC automatic lathe, occupies an important position in the field of precision manufacturing due to its excellent performance and wide application areas. This machine tool not only integrates mechanical and electrical technologies, but also becomes an indispensable processing equipment in many industrial fields due to its...
Recently, Toshiba announced that in the field of LiDAR lidar for distance measurement, it has developed a technology that can track vehicles, people, and other objects with 99.9% accuracy, achieving the world's highest accuracy. And only using LiDAR to collect data can achieve 98.9% object recognition.In addition, the detection distance in rainstorm and dense fog environments has been increased by...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...